These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 32868648)
1. Long noncoding RNA TTTY15 promotes growth and metastasis of esophageal squamous cell carcinoma by sponging microRNA-337-3p to upregulate the expression of JAK2. Wang W; Yang J Anticancer Drugs; 2020 Nov; 31(10):1038-1045. PubMed ID: 32868648 [TBL] [Abstract][Full Text] [Related]
2. miR-133a-3p suppresses cell proliferation, migration, and invasion and promotes apoptosis in esophageal squamous cell carcinoma. Yin Y; Du L; Li X; Zhang X; Gao Y J Cell Physiol; 2019 Aug; 234(8):12757-12770. PubMed ID: 30537034 [TBL] [Abstract][Full Text] [Related]
3. LncRNA TUG1 contributes to ESCC progression via regulating miR-148a-3p/MCL-1/Wnt/β-catenin axis in vitro. Tang Y; Yang P; Zhu Y; Su Y Thorac Cancer; 2020 Jan; 11(1):82-94. PubMed ID: 31742924 [TBL] [Abstract][Full Text] [Related]
4. Silencing of Long Noncoding RNA SNHG6 Inhibits Esophageal Squamous Cell Carcinoma Progression via miR-186-5p/HIF1α Axis. Du F; Guo T; Cao C Dig Dis Sci; 2020 Oct; 65(10):2844-2852. PubMed ID: 31853782 [TBL] [Abstract][Full Text] [Related]
5. LncRNA testis-specific transcript, Y-linked 15 (TTTY15) promotes proliferation, migration and invasion of colorectal cancer cells via regulating miR-29a-3p/DVL3 axis. Zheng XY; Cao MZ; Ba Y; Li YF; Ye JL Cancer Biomark; 2021; 31(1):1-11. PubMed ID: 33016900 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA XIST promotes the progression of esophageal squamous cell carcinoma through sponging miR-129-5p and upregulating CCND1 expression. Wang H; Li H; Yu Y; Jiang Q; Zhang R; Sun H; Xing W; Li Y Cell Cycle; 2021 Jan; 20(1):39-53. PubMed ID: 33345719 [TBL] [Abstract][Full Text] [Related]
7. MiR-601 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma (ESCC) by targeting HDAC6. Liu C; Tian X; Sun HB; Wang ZF; Jiang LF; Li ZX Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1069-1076. PubMed ID: 30779074 [TBL] [Abstract][Full Text] [Related]
8. A novel long noncoding RNA, LOC440173, promotes the progression of esophageal squamous cell carcinoma by modulating the miR-30d-5p/HDAC9 axis and the epithelial-mesenchymal transition. Wang G; Feng B; Niu Y; Wu J; Yang Y; Shen S; Guo Y; Liang J; Guo W; Dong Z Mol Carcinog; 2020 Dec; 59(12):1392-1408. PubMed ID: 33079409 [TBL] [Abstract][Full Text] [Related]
9. Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway. Xu Z; Tie X; Li N; Yi Z; Shen F; Zhang Y IUBMB Life; 2020 Mar; 72(3):426-439. PubMed ID: 31778020 [TBL] [Abstract][Full Text] [Related]
10. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p. Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma. Zuo J; Zhao M; Fan Z; Liu B; Wang Y; Li Y; Lv P; Xing L; Zhang X; Shen H Thorac Cancer; 2020 Mar; 11(3):738-747. PubMed ID: 32012470 [TBL] [Abstract][Full Text] [Related]
12. Circ_0001093 promotes glutamine metabolism and cancer progression of esophageal squamous cell carcinoma by targeting miR-579-3p/glutaminase axis. Qian CJ; Tong YY; Wang YC; Teng XS; Yao J J Bioenerg Biomembr; 2022 Apr; 54(2):119-134. PubMed ID: 35322289 [TBL] [Abstract][Full Text] [Related]
13. lncTUG1/miR-144-3p affect the radiosensitivity of esophageal squamous cell carcinoma by competitively regulating c-MET. Wang P; Yang Z; Ye T; Shao F; Li J; Sun N; He J J Exp Clin Cancer Res; 2020 Jan; 39(1):7. PubMed ID: 31918742 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA SLC2A1-AS1 induced by GLI3 promotes aerobic glycolysis and progression in esophageal squamous cell carcinoma by sponging miR-378a-3p to enhance Glut1 expression. Liu H; Zhang Q; Song Y; Hao Y; Cui Y; Zhang X; Zhang X; Qin Y; Zhu G; Wang F; Dang J; Ma S; Zhang Y; Guo W; Li S; Guan F; Fan T J Exp Clin Cancer Res; 2021 Sep; 40(1):287. PubMed ID: 34517880 [TBL] [Abstract][Full Text] [Related]
15. LncRNA ZEB2-AS1 promotes the proliferation, migration and invasion of esophageal squamous cell carcinoma cell through miR-574-3p/HMGA2 axis. Xu JH; Chen RZ; Liu LY; Li XM; Wu CP; Zhou YT; Yan JD; Zhang ZY Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5391-5403. PubMed ID: 32495874 [TBL] [Abstract][Full Text] [Related]
16. [MIR503HG promotes esophageal squamous cell carcinoma cell proliferation, invasion and migration via hsa-miR-503 pathway]. Gong TY; Chen HY; Liu ZH Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1160-1167. PubMed ID: 36380664 [No Abstract] [Full Text] [Related]
17. Long noncoding RNA lnc-ABCA12-3 promotes cell migration, invasion, and proliferation by regulating fibronectin 1 in esophageal squamous cell carcinoma. Ma J; Xiao Y; Tian B; Chen S; Zhang B; Wu J; Wu Z; Li X; Tang J; Yang D; Zhou Y; Wang H; Su M; Wang W J Cell Biochem; 2020 Feb; 121(2):1374-1387. PubMed ID: 31512786 [TBL] [Abstract][Full Text] [Related]
18. MiR-874-3p is an independent prognostic factor and functions as an anti-oncomir in esophageal squamous cell carcinoma via targeting STAT3. Yuan RB; Zhang SH; He Y; Zhang XY; Zhang YB Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7265-7273. PubMed ID: 30468470 [TBL] [Abstract][Full Text] [Related]
19. Knockdown of lncRNAXLOC_001659 inhibits proliferation and invasion of esophageal squamous cell carcinoma cells. Li FZ; Zang WQ World J Gastroenterol; 2019 Nov; 25(42):6299-6310. PubMed ID: 31754291 [TBL] [Abstract][Full Text] [Related]
20. Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC). Lu YF; Yu JR; Yang Z; Zhu GX; Gao P; Wang H; Chen SY; Zhang J; Liu MY; Niu Y; Wei XM; Wang W; Ye FJ; Zhang LX; Zhao Y; Sun GG J Exp Clin Cancer Res; 2018 Dec; 37(1):301. PubMed ID: 30514328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]